Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To evaluated the aggressive potential of brain tumors related to cell proliferation index measured by [18F]FLT
Day 10
No
Jean-Sébastien Guillamo, MD, PhD
Principal Investigator
University Hospital, Caen
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
2007-006265-32
NCT00850278
October 2008
July 2011
Name | Location |
---|